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Abstract
Background: Reliable, population-based data on pregnancy-related morbidity and mortality, and risk factors for
fatal foetal outcomes are scarce for low- and middle-income countries. Yet, such data are essential for understanding
and improving maternal and neonatal health and wellbeing.
Methods: Within the 4-monthly surveillance rounds of the Taabo health and demographic surveillance system (HDSS)
in south-central Côte d’Ivoire, all women of reproductive age identified to be pregnant between 2011 and 2014 were
followed-up. A questionnaire pertaining to antenatal care, pregnancy-related morbidities, delivery circumstances, and
birth outcome was administered to eligible women. Along with sociodemographic information retrieved from the
Taabo HDSS repository, these data were subjected to penalized maximum likelihood logistic regression analysis, to
determine risk factors for fatal foetal outcomes.
Results: A total of 2976 pregnancies were monitored of which 118 (4.0%) resulted in a fatal outcome. Risk factors
identified by multivariable logistic regression analysis included sociodemographic factors of the expectant mother,
such as residency in a rural area (adjusted odds ratio (aOR) = 2.87; 95% confidence interval (CI) 1.31–6.29) and poorest
wealth tertile (aOR = 1.79; 95% CI 1.02–3.14), a history of miscarriage (aOR = 23.19; 95% CI 14.71–36.55), non-receipt of
preventive treatment such as iron/folic acid supplementation (aOR = 3.15; 95% CI 1.71–5.80), only two doses of tetanus
vaccination (aOR = 2.59; 95% CI 1.56–4.30), malaria during pregnancy (aOR = 1.94; 95% CI 1.21–3.11), preterm birth (aOR
= 4.45; 95% CI 2.82–7.01), and delivery by caesarean section (aOR = 13.03; 95% CI 4.24–40.08) or by instrumental
delivery (aOR = 5.05; 95% CI 1.50–16.96). Women who paid for delivery were at a significantly lower odds of
a fatal foetal outcome (aOR = 0.39; 95% CI 0.25–0.74).
Conclusions: We identified risk factors for fatal foetal outcomes in a mainly rural HDSS site of Côte d’Ivoire.
Our findings call for public health action to improve access to, and use of, quality services of ante- and perinatal care.
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Background
While major progress has been made over the past
15 years to improve population health and wellbeing [1],
maternal and neonatal mortality still remain high, par-
ticularly in the poorest countries, where stillbirths occur
frequently [2, 3]. Pregnancy-related morbidity and com-
plications during childbirth have a significant negative
impact on the foetus and may result in fatal outcomes
[4, 5]. Fatal foetal outcome include miscarriage (early
foetal death), stillbirth, and early neonatal mortality.
Miscarriage is usually considered as pregnancy loss of a
foetus that did not yet reach the gestational age of
23 weeks or a weight inferior to 500 g in case gestational
age is unknown [6, 7]. For international comparison,
however, the World Health Organization (WHO), rec-
ommends to use the definition of a child born dead of at
least 28 weeks of gestational age with a birth weight over
1000 g or a birth size ≥35 cm to discriminate between
miscarriage and stillbirth [7]. Neonatal death, considered
death of a live birth within the first 28 days of life, is fur-
ther subdivided into early (up to 7 days of life) and late
neonatal death (8–28 days of life) [7]. For 2015, there
were an estimated 2.12 million stillbirths, and an add-
itional 2.03 million early neonatal deaths, thus death oc-
curring within 7 days after a live birth [2]. Stillbirth and
neonatal death also come at a substantial direct, indirect,
and tangible cost, not only to the mothers and fathers
and their family, but also staff who care for them and
the society at large [8].
There is a paucity of data in low-income countries
pertaining to the incidence of foetal deaths, partially ex-
plained by the lack of designated health policies, pro-
grammes, and adequate surveillance platforms [9].
While a panoply of maternal and foetal factors are
recognised for stillbirths, estimates on their importance
in contributing to a fatal foetal outcome are based on
theoretical constructs using mathematical modelling of
prevalence estimates of “known” associated risk factors
in the population [10]. However, these estimates usually
lack accuracy, as data are poorly reported or not re-
ported at all. The majority of foetal and early neonatal
deaths are estimated to occur in South Asia and
sub-Saharan Africa [11, 12]. Yet, in these regions, there
is underreporting due to a lack of data repositories on
neonatal mortality, stillbirth, miscarriage, and induced
abortion. In general, foetal deaths are not routinely re-
ported and included in essential population statistics of
many low- and middle-income countries [13]. In Côte
d’Ivoire, for example, more than 40% of deliveries occur
outside a health facility, and hence, risk factors for fatal
foetal outcomes remain to be thoroughly investigated
[14]. Moreover, the often found preference for trad-
itional birth assistance and non-facility-based deliveries,
paired with reluctance towards the use of antenatal care,
may put expectant mothers and their unborn babies
at additional risks [15–17]. There is a pressing need
for quality information regarding pregnancy-related
morbidity and health system use in order to better
understand risk factors of pregnancy complications,
so that foetal and maternal death rates can be
lowered [18].
The Taabo health and demographic surveillance sys-
tem (HDSS) in south-central Côte d’Ivoire – like other
members of the International Network for the continu-
ous Demographic Evaluation of Populations and their
Health (INDEPTH) – documents pregnancy-related
morbidity and other vital statistics in a distinct geo-
graphic region at the household level [19]. We investi-
gated the most important pregnancy-related morbidities
and factors associated with fatal foetal outcomes in the
Taabo HDSS, including all pregnancies starting and end-
ing between January 1, 2011 and December 31, 2014.
Our findings, although not representative for the whole
of Côte d’Ivoire, provide an evidence-base and allow for
priority setting in order to improve maternal and neo-
natal health in rural areas of Côte d’Ivoire and elsewhere
in sub-Saharan Africa.
Methods
Study area and design
This study was conducted within the Taabo HDSS [20, 21].
The Taabo HDSS includes one small town (Taabo Cité),
which is the centre of the department of Taabo that also
holds the only small hospital for the surveillance zone.
There are 13 main villages with more than 100 associated
hamlets. The latter are settlements usually consisting of a
group of households constructed close to agricultural ex-
ploitation sites, rather isolated, and not yet officially consid-
ered a village by the territorial administrative authority
mainly due to its small population size (< 500 inhabitants).
Meanwhile, there is a primary health care centre in all of
the 13 villages, 10 of which were fully operational with an
assigned nurse and three are managed by trained
community-health workers (CHWs) not yet being entirely
functional. In the hamlets, no basic primary care is available
but CHWs that are part of the hamlet’s population may be
approached for advice before seeking formal care. Basic
antenatal care is provided at the general hospital of Taabo
and all nurse-led operational health centres; thereof four
villages also host professional midwives who offer their ser-
vice. With regard to emergency obstetric care (EOC), such
as caesarean section and instrumental delivery (e.g. forceps
delivery), the first is supposed to be only done at the gen-
eral hospital of Taabo where an operating block is available,
while instrumental deliveries may also being performed as
emergency measure by midwives. For women delivering in
a health facility, referral to a better equipped medical centre
in case of complications is decided and an official transfer
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statement provided by the respective midwives. However,
the actual transport remains to be organised by the
women’s relatives due to a lack of ambulances (only avail-
able in Taabo-Cité and the village of Kotiéssou). The costs
for antenatal care and birth assistance are not standardised
and thus difficult to be estimated. Certainly the costs in-
crease with the level of proficiency of the service providers
and depend on whether facilities are public or private [17].
Since 2011 antenatal care and delivery are by national pol-
icy free of charge, however additional costs for health seek-
ing by expectant mothers are common [22]. Of note, in
primarily rural areas such as the Taabo HDSS many
women, especially when it is their first child, still tend to
spend the last trimester of their pregnancy close to their
relatives that may live in more remote areas. The place of
labour and child birth may thus differ in many cases from
the actual residence of the expectant mothers.
The objective of this study was to assess pregnancy-re-
lated morbidities and risk factors for a fatal foetal out-
come. All women of reproductive age (15–49 years)
whose pregnancy started and ended between January 1,
2011 and December 31, 2014 were included. Each
household of the Taabo HDSS is visited at least three
times a year for detailed surveillance of vital events (i.e.
birth, death, in-migration, out-migration, and preg-
nancy). New pregnancies were systematically listed and
followed-up longitudinally. The status and potential
negative events related to pregnancy were registered by
trained field-enumerators. Miscarriage, stillbirth, and live
birth were registered as pregnancy outcomes.
Each woman identified with a new pregnancy was inter-
viewed with a pre-tested questionnaire with an emphasis
on pregnancy status, estimated date of last menstrual
period (LMP), and number of earlier pregnancies and
births. Furthermore, in relation to potential negative
consequences of a pregnancy, a standardised INDEPTH
questionnaire on pregnancy-related morbidity was admin-
istered by field-enumerators to expectant mothers [23].
Sociodemographic information from women becoming
pregnant during the 4-year observational study was readily
available from the Taabo HDSS database [20].
Statistical analysis
Data were double-entered, cross-checked, and managed
using a household registration system implemented in
Windev version 12.0 (PC Soft; Montpellier, France) [24].
All statistical analyses were performed in Stata version
12.0 (StataCorp; College Station, TX, USA). Data records
from pregnant women with complete sociodemographic,
pregnancy-related morbidity, and birth circumstances
information that were not lost to follow-up were consid-
ered for analysis (Fig. 1).
The primary outcome variable was defined as fatal
foetal outcome and applied to all pregnancies that
resulted in stillbirth, miscarriage, or early neonatal death
using WHO definitions (i.e. dead born with gestational
age higher or lower than 28 weeks, or death within the
first 7 days after birth) [7]. Assessed explanatory vari-
ables for relationship analysis included (i) sociodemo-
graphic characteristics of the expectant mother; (ii)
antenatal care sought; (iii) pregnancy-related morbidities
and concomitant health conditions; and (iv) circumstances
of delivery reported. Socioeconomic status was deter-
mined using a household-based asset approach and prin-
cipal component analysis (PCA) with stratification into
wealth tertiles (i.e. poorest, poor, and least poor) [25].
Gestational age at birth was calculated based on the first
day of LMP and date of birth. Preterm birth was defined
as gestational age < 37 weeks [26] or as perceived “shorter
than normal” (i.e. estimated duration of < 8 months) pre-
term birth in women not able to provide reliable informa-
tion on LMP (about 8% of all expectant mothers).
χ2 test statistics were used to investigate significant
univariate differences between mothers whose pregnancy
resulted in live birth compared to a fatal outcome for
the aforementioned explanatory variables. Univariate
and multivariable logistic regression analyses were per-
formed to identify significant relationships between fatal
foetal outcome and covariates. In order to address
estimation bias from fatal foetal outcome being a rare
event, penalized maximum likelihood logistic regression
models, as proposed by Firth, were used [27, 28]. Results
were presented as odds ratios (ORs) and 95% confidence
interval (CI). Differences and relationships with a
p-value below 0.05 were considered as statistically sig-
nificant. The multivariable regression model was built
using a stepwise elimination approach, excluding ex-
planatory variables at a significance level of 0.20 or
higher. Sociodemographic factors known to have nega-
tive consequences on birth outcome (e.g. age, socioeco-
nomic status, and residency of the mother) from earlier
studies were included in the final model [29].
Results
Study sample and sociodemographic characteristics
From a total of 3070 pregnancies registered in the Taabo
HDSS over a 4-year period, 3009 were monitored from
start to finish. Sixty-one pregnant women out-migrated
from the surveillance area or were lost-to-follow-up.
Another thirty-three expectant mothers had no informa-
tion on pregnancy-related morbidity and birth circum-
stances, as assessed during the questionnaire interview
(Fig. 1). Taken together, 2976 monitored pregnancies
had complete data records, and hence, were considered
as final study sample. Within these fully monitored preg-
nancies 2858 (96.0%) resulted in live birth. The
remaining 118 (4.0%) were fatal foetal outcomes and are
the subject of the current in-depth analysis.
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There were 63 (53.4%) stillbirths (gestational age
≥ 28 weeks), 35 (29.7%) early neonatal deaths (live birth
with death within the first 7 days), and 20 known
(16.9%) miscarriages (gestational age estimated < 28 weeks).
Our findings translate into a miscarriage rate of 6.7, a
stillbirth rate of 21.2 and an early neonatal death
rate of 11.8 per 1000 births. The latter two rates
are summed up into a perinatal mortality of 32.9 per
1000 births. Only a small proportion of the expectant
mothers were urban residents (12.8%), while the large
majority lived in rural areas (87.2%). More than four out
of five mothers were below the age of 35 years (83.3%).
Women with no or low educational attainment repre-
sented 62.8% and 28.8%, respectively, of all pregnancies
investigated. Most of the women lived with a partner, ei-
ther legally married (51.0%) or in a common-law rela-
tionship (40.5%). With regard to religion, more than half
of the mothers reported that they are animist (51.0%),
while Muslim and Christians accounted for 40.7% and
7.7%, respectively. Univariate regression analysis revealed
no statistically significant association between foetal out-
come and sociodemographic characteristics of the ex-
pectant mothers, such as age, educational attainment,
alphabetisation, socioeconomic and marital status, reli-
gion, or residency (Table 1).
Antenatal care, birth circumstances, and foetal outcome
As shown in Table 2, univariate regression analysis re-
vealed several significant associations between fatal
foetal outcome and antenatal care and birth circum-
stances. Antenatal care, such as visits of health care
centres during pregnancy, iron and folic acid supple-
mentation, and receipt of two doses of tetanus vaccine
were negatively associated with fatal foetal outcome.
Women without antenatal care visits (3.7%) were more
likely to experience negative consequences on their
foetus’ health compared to women going for check-ups
(OR = 4.56; 95% CI 2.59–8.03). Women who did not re-
ceive two doses of tetanus (55.7%) had a higher odds of
a fatal outcome (OR = 3.07; 95% CI 1.96–4.81). Similarly,
women who lacked iron and folic supplementation were
at higher odds of fatal foetal outcome (OR = 2.37; 95%
CI 1.41–3.99).
Concerning birth circumstances, it was found that,
compared to women who gave birth in hamlets (10.2%),
those giving birth in main villages of the Taabo HDSS
(59.1%) were at a higher odds of experiencing a fatal out-
come (OR = 3.11; 95% CI 1.19–8.09). Home deliveries
were not associated with an increased odds for fatal
foetal outcome (OR = 0.88, 95% CI 0.60–1.27) compared
to facility-based deliveries in univariate analysis. If only
vaginal births were considered, excluding EOC such as
caesarean section and delivery using instruments, facil-
ity- and home-based deliveries showed comparable fatal-
ity rates of 35.4 and 37.4 fatal events per 1000 births,
respectively. Nevertheless, the place of delivery plays a
role if the mother’s residency is taken into account.
Figure 2 shows the main places of delivery for women
from hamlets, villages, and the urban town of Taabo and
provides estimations of fatal outcome rates for each of
these places, stratified by the mother’s residence.
Women with urban residency had the highest propor-
tion of facility-based deliveries (91.9%), whilst most used
the health services of the Taabo general hospital (80.9%).
If translated into number of fatal events per 1000 births,
the findings further highlight higher fatality rates in fa-
cilities for non-resident mothers. For example, mothers
from hamlets and the town using health centres of vil-
lages had a higher fatality rate compared to mothers
from villages using the same health centres (73.5 and
Fig. 1 Flow chart indicating all pregnancies registered and monitored between 2011 and 2014 in the Taabo HDSS and final study sample comprising
complete data for analysis
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153.8 vs. 37.8 per 1000 births). Similarly, mothers resid-
ing in the town had a lower incidence of fatal outcomes,
compared to hamlet and village mothers delivering at
the town’s hospital (22.7 vs. 58.8 and 68.3 per 1000
births). Women of hamlets (51.9%) and villages (47.8%)
showed comparable rates of home deliveries, as defined
as non-facility based delivery at own residency. Fatality
rates, however, were higher in the village settings (10.3
vs. 45.3 per 1000 births).
With regard to the type of birth assistance, only deliv-
eries without any birth assistance (2.4% of all deliveries)
were more likely to terminate in stillbirth or early neo-
natal death (OR = 3.74; 95% CI 1.83–7.64) if compared
to deliveries assisted by qualified medical personnel
(48.8%). Assistance by family members/friends (34.6%),
traditional birth assistants (11.9%), or other assistance
(0.3%) than professional medical personnel did not show
increased ORs for a fatal outcome in univariate regres-
sion analysis. Caesarean section and instrumental deliv-
eries were associated with higher odds of fatal foetal
outcomes (OR = 7.65; 95% CI 3.48–16.81 and OR = 5.12;
95% CI 2.02–13.03, respectively). Figure 3 illustrates
numbers of such EOC measures undertaken and their
fatality ratio and percentage in the general hospital of
Taabo, the village-based health centres within and out-
side the Taabo HDSS. The overall percentage of fatal
Table 1 Mother’s sociodemographic characteristics, stratified by foetal outcome and crude ORs for fatal outcome, in the Taabo
HDSS in 2011–2014, as assessed by univariate logistic regression analysis
Sociodemographic characteristics Foetal outcome
Live birtha Fatal birth Total
2858 (96.0) 118 (4.0) 2976 (100.0) OR (95% CI) P-value
Maternal age (years)
20–34 1994 (69.8) 80 (67.8) 2074 (69.7) 1.00
≤19 389 (13.6) 16 (13.6) 405 (13.6) 1.05 (0.61, 1.80) 0.861
≥35 475 (16.6) 22 (18.6) 497 (16.7) 1.17 (0.73, 1.89) 0.514
Educational attainment
Never attended school 1795 (62.8) 75 (63.6) 1870 (62.8) 1.00
Primary school 823 (28.8) 34 (28.8) 857 (28.8) 0.99 (0.65, 1.50) 0.957
Secondary school or higher 240 (8.4) 9 (7.6) 249 (8.4) 0.90 (0.44, 1.82) 0.763
Literacy
Literate 578 (20.2) 21 (17.8) 599 (20.1) 1.00
Illiterate 2280 (79.8) 97 (82.2) 2377 (79.9) 1.17 (0.72, 1.89) 0.520
Socioeconomic status (wealth tertile)
Least poor 955 (33.4) 35 (29.7) 990 (33.2) 1.00
Poor 957 (33.5) 36 (30.5) 993 (33.4) 1.03 (0.64, 1.64) 0.915
Most poor 946 (33.1) 47 (39.8) 993 (33.4) 1.35 (0.87, 2.11) 0.184
Marital status
Unmarried 221 (7.7) 14 (11.9) 235 (7.9) 1.00
Common-law union 1164 (40.7) 41 (34.7) 1205 (40.5) 0.54 (0.29, 1.01) 0.053
Married 1457 (51.0) 62 (52.5) 1519 (51.0) 0.66 (0.36, 1.18) 0.159
Divorced/widowed 16 (0.6) 1 (0.9) 17 (0.6) 1.39 (0.24, 8.02) 0.714
Religion
Christian 221 (7.7) 14 (11.9) 235 (7.9) 1.00
Muslim 1164 (40.7) 41 (34.7) 1205 (40.5) 0.99 (0.66, 1.48) 0.961
Animist 1457 (51.0) 62 (52.5) 1519 (51.0) 0.33 (0.02, 5.46) 0.439
Other religion 16 (0.6) 1 (0.8) 14 (0.6) 0.62 (0.34, 1.15) 0.129
Residency
Urban 371 (13.0) 11 (9.3) 382 (12.8) 1.00
Rural 2486 (87.0) 107 (90.7) 2594 (87.2) 1.45 (0.77, 2.73) 0.246
aIncludes all live births with survival of more than 7 days
CI confidence interval, OR odds ratio
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Table 2 Use of antenatal care and birth circumstances in the Taabo HDSS in 2011–2014, stratified by foetal outcome, and crude ORs
for fatal outcome from univariate logistic regression analysis
Foetal outcome
Characteristics Live birtha Fatal birth Total
2858 (96.0) 118 (4.0) 2976 (100.0) OR (95% CI) P-value
Antenatal care
Antenatal visits
Yes 2763 (96.7) 102 (86.4) 2865 (96.3) 1.00
No 95 (3.3) 16 (13.6) 111 (3.7) 4.56 (2.59, 8.03) < 0.001*
Rubella test
Yes 138 (4.8) 4 (3.4) 142 (4.8) 1.00
No 2720 (95.2) 114 (96.6) 2834 (95.2) 1.30 (0.50, 3.37) 0.596
HIV test
Yes 539 (18.9) 14 (11.9) 553 (18.6) 1.00
No 2319 (81.1) 104 (88.1) 2423 (81.4) 1.73 (0.98, 3.04) 0.058
Two doses of tetanus vaccination
Yes 1293 (45.2) 25 (21.2) 1318 (44.3) 1.00
No 1565 (54.8) 93 (78.8) 1658 (55.7) 3.07 (1.96, 4.81) < 0.001*
Iron/folic acid supplementation
Yes 816 (28.6) 17 (14.4) 833 (28.0) 1.00
No 2042 (71.4) 101 (85.6) 2143 (72.0) 2.37 (1.41, 3.99) 0.001*
Syphilis test
Yes 425 (14.9) 12 (10.2) 437 (14.7) 1.00
No 2433 (85.1) 102 (89.8) 2539 (85.3) 1.54 (0.84, 2.83) 0.161
Birth circumstances
Location during delivery
HDSS hamlets 299 (10.5) 4 (3.4) 303 (10.2) 1.00
HDSS village 1682 (58.8) 78 (66.1) 1760 (59.1) 3.11 (1.19, 8.09) 0.020*
Taabo-cité 538 (18.8) 22 (18.6) 560 (18.8) 2.78 (1.00, 7.73) 0.050
Outside Taabo HDSS 339 (11.9) 14 (11.9) 353 (11.9) 2.84 (0.98, 8.28) 0.055
Place of delivery
Health centre/hospital 1419 (49.6) 63 (53.4) 1482 (49.8) 1.00
At home 1340 (46.9) 52 (44.1) 1392 (46.8) 0.88 (0.60, 1.27) 0.485
On the way to health centre 22 (0.8) 2 (1.7) 24 (0.8) 2.48 (0.66, 9.40) 0.180
Other 77 (2.7) 1 (0.8) 78 (2.6) 0.43 (0.08, 2.22) 0.315
Birth assistance
Midwife/doctor/nurse 1390 (48.6) 61 (51.7) 1451 (48.8) 1.00
Traditional birth assistance 341 (11.9) 13 (11.0) 354 (11.9) 0.69 (0.47, 1.60) 0.651
Alone 61 (2.1) 10 (8.5) 71 (2.4) 3.74 (1.83,7.64) < 0.001*
Parent/friend 997 (34.9) 33 (28.0) 1030 (34.6) 0.75 (0.49, 1.16) 0.200
Other 69 (2.4) 1 (0.8) 70 (2.3) 0.33 (0.05, 2.42) 0.275
Delivery
Normal 2801 (98.0) 105 (89.0) 2906 (97.7) 1.00
Caesarean section 29 (1.0) 8 (6.8) 37 (1.2) 7.65 (3.48, 16.81) < 0.001*
Instrumental delivery 28 (1.0) 5 (4.2) 33 (1.1) 5.12 (2.02, 13.03) 0.001*
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foetal events for caesarean section (eight out of 37;
21.6%) and instrumental delivery (five out of 33; 15.2%)
were very high. The general hospital of Taabo showed a
higher fatality ratio and percentage of fatal events from
caesarean section (fatal (F):non-fatal (NF) ratio = 3:7;
30%), while health centres outside the Taabo HDSS
showed a higher fatality ratio in instrumental delivery
(F:NF ratio = 5:17; 23%) compared to zero fatal events
(0:11; 0%) within the Taabo HDSS facilities.
One-fifth of all women reported to have experienced
heavy bleeding during delivery, which was found to be
associated with a negative impact on the foetal health
Table 2 Use of antenatal care and birth circumstances in the Taabo HDSS in 2011–2014, stratified by foetal outcome, and crude ORs
for fatal outcome from univariate logistic regression analysis (Continued)
Foetal outcome
Characteristics Live birtha Fatal birth Total
2858 (96.0) 118 (4.0) 2976 (100.0) OR (95% CI) P-value
Heavy bleeding during delivery
No/cannot remember 2301 (80.5) 81 (68.6) 2382 (80.0) 1.00
Yes 557 (19.5) 37 (31.4) 594 (20.0) 1.90 (1.28, 2.83) 0.002*
Childbirth costs
Mean amount, in FCFA (min-max) 14,479 (500–996,000) 30,066 (1000–400,000) 15,004 (500–996,000)
Free of charge 388 (13.6) 31 (26.3) 419 (14.1) 1.00
Payment of charge 606 (21.2) 22 (18.6) 628 (21.1) 0.45 (0.26, 0.80) 0.006*
Do not know 1864 (65.2) 65 (55.1) 1929 (64.8) 0.44 (0.28, 0.68) < 0.001*
CI confidence interval, OR odds ratio
*Includes all live births with survival of more than 7 days
Fig. 2 Proportion of place of delivery by residency of the mother and corresponding numbers of fatal events for each place by residency among
2976 pregnancies monitored during a 4-year period in 2011–2014 in the Taabo HDSS. Greyish categories for place of delivery highlight places at
the mothers own residency
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(OR = 1.90; 95% CI 1.28–2.83) (Table 2). The mean cost
of delivery was approximately FCFA 15,000 (approxi-
mately US$ 25). Our findings highlight a lower risk for
fatal outcome in deliveries with assistance offered at a
fee (irrespective of whether the amount is known (OR =
0.45; 95% CI 0.26–0.80) or not (OR = 0.44; 95% CI 0.28–
0.68)), compared to those free of charge. Other potential
factors, such as rubella, syphilis, and HIV testing,
showed no significant association with foetal death in
the univariate analysis.
Pregnancy-related morbidities or concomitant health
conditions and foetal outcome
Univariate logistic regression analysis showed several asso-
ciations between pregnancy-related morbidities and other
health conditions of expectant mothers and the foetal
health outcome (Table 3). 7.8% of pregnant women in-
cluded in the study had already experienced miscarriage or
stillbirth in a previous pregnancy. For these women the risk
for another fatal foetal outcome was strikingly high (OR =
22.34; 95% CI 15.01–33.25). Furthermore, morbidities of
the genital tract, such as bleeding and discharge, had an in-
fluence on the foetal outcome. Women who had bleeding
during pregnancy, be it in small quantities (2.7%; OR =
4.34; 95% CI 2.23–8.45) or accompanied by abdominal pain
(3.5%; OR = 2.27; 95% CI 1.07–4.79), showed a higher odds
to lose their child by miscarriage, stillbirth, or early neonatal
death than their counterparts without bleeding.
Foul-smelling vaginal discharge during pregnancy, which
might indicate a genital infection, was reported by 20.9% of
the women and was associated with increased odds for a
fatal outcome (OR= 1.63; 95% CI 1.09–2.45).
Concomitant diseases during pregnancy manifested a
detrimental effect on the unborn child. Malaria (55.7%;
OR = 1.78; 95% CI 1.20–2.65), jaundice (14.3%; OR =
1.84; 95% CI 1.18–2.86), and urinary tract infections
(12.6%; OR = 2.03; 95% CI 1.29–3.17) ranked among the
most important ones. Besides these morbidities and dis-
eases, low gestational age (preterm birth at < 37 weeks,
15.2% of all births) was found a major risk factor for
non-survival of the foetus (OR = 5.23; 95% CI 3.59–
7.63). Known other co-morbidities during pregnancy,
such as oedema, hypertension, and fever showed no sig-
nificant relationship with foetal health in the Taabo
HDSS during the 4-year observation period.
Significant risk factors for fatal foetal outcome
Table 4 summarises all significant risk factors for a fatal
foetal outcome, as revealed by multivariable logistic re-
gression modelling. In terms of sociodemographic char-
acteristics, women living in a rural area and from the
poorest wealth tertile were at higher odds of experien-
cing foetal or neonatal death (aOR = 2.87; 95% CI 1.31–
6.29 and aOR = 1.79; 95% CI 1.02–3.14, respectively). A
prior history of miscarriage or stillbirth (aOR = 23.19;
95% CI 14.71–36.55) and giving birth by caesarean sec-
tion (aOR = 13.03; 95% CI 4.24–40.08) or by instrumen-
tal delivery (aOR = 5.05; 95% CI 1.50–16.96) were major
risk factors for an unfavourable foetal outcome in the
adjusted model. Preterm birth (< 37 weeks of gestational
age) showed a major impact on the health of the foetus
after adjustment (aOR = 4.45; 95% CI 2.82–7.01). Fur-
ther, payment for delivery was associated with a lower
odds of fatal outcome (aOR = 0.39; 95% CI 0.25–0.74).
Fig. 3 Type of emergency obstetric care (EOC) measures undertaken (n = 70) and fatality ratio (number fatal:number non-fatal) and prevalence
(%) by type of health care provider as assessed during monitoring of all pregnancies in the Taabo HDSS from 2011 to 2014. 1st ring: type of
emergency obstetric care (EOC) (i.e. caesarean section and instrumental delivery, n), 2nd ring: EOCs by health care provider, 3rd ring: number
of fatal (F, darkened) and non-fatal (NF) EOC birth outcomes by health care provider
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Women not having received tetanus vaccination (aOR
= 2.59; 95% CI 1.56–4.30) and women without iron/
folic acid supplementation during pregnancy (aOR =
3.15; 95% CI 1.71–5.80) were at higher odds of mis-
carriage, stillbirth, or early neonatal death, compared
to women covered by prevention efforts. With regard
to pregnancy-related morbidities and concomitant
health conditions, malaria during pregnancy was
significantly associated with a fatal foetal outcome in
the multivariable logistic regression model (aOR =
1.94; 95% CI 1.21–3.11). Vaginal bleeding of small
quantities during pregnancy was no longer signifi-
cantly associated with a fatal foetal outcome (p > 0.05)
after adjustment to all other included covariates,
while it remained a risk factor in the multivariable
model (aOR = 1.98; 95% CI 0.94–4.15).
Table 3 Pregnancy-related morbidities or concomitant health conditions in the Taabo HDSS in 2011–2014, stratified by foetal outcome,
and crude ORs for fatal outcome from univariate logistic regression analysis
Foetal outcome
Characteristics Live birth* Fatal birth Total
2858 (96.0) 118 (4.0) 2976 (100.0) OR (95% CI) P-value
Pregnancy-related morbidities or concomitant health conditions
Earlier miscarriage/stillbirth
No 2694 (94.3) 50 (42.4) 2744 (92.2) 1.00
Yes 164 (5.7) 68 (57.6) 232 (7.8) 22.34 (15.01, 33.25) < 0.001*
Vaginal bleeding during pregnancy
No/cannot remember 2693 (94.2) 99 (83.9) 2792 (93.8) 1.00
Yes, in small quantities 69 (2.4) 11 (9.3) 80 (2.7) 4.34 (2.23, 8.45) < 0.001*
Yes, with preceding abdominal pain 96 (3.4) 8 (6.8) 104 (3.5) 2.27 (1.07, 4.79) 0.032*
Oedema of extremities or face
No/cannot remember 2222 (77.7) 93 (78.8) 2315 (77.8) 1.00
Yes 636 (22.3) 25 (21.2) 661 (22.2) 1.07 (0.68, 1.67) 0.785
Hypertension
No/cannot remember 2829 (99.0) 116 (98.4) 2945 (99.0) 1.00
Before pregnancy 13 (0.4) 1 (0.8) 14 (0.5) 0.49 (0.13, 1.79) 0.279
During pregnancy 16 (0.6) 1 (0.8) 17 (0.6) 0.62 (0.08, 5.01) 0.655
Persistent fever
No/cannot remember 1769 (61.9) 63 (53.4) 1832 (61.6) 1.00
Yes 1089 (38.1) 55 (46.6) 1144 (38.4) 1.42 (0.98, 2.05) 0.064
Malaria (reported or confirmed)
No/cannot remember 1282 (44.9) 37 (31.4) 1319 (44.3) 1.00
Yes 1576 (55.1) 81 (68.6) 1657 (55.7) 1.78 (1.20, 2.65) 0.004*
Urinary tract infection (dysuria)
No/cannot remember 2508 (87.7) 92 (78.0) 2600 (87.4) 1.00
Yes 350 (12.3) 26 (22.0) 376 (12.6) 2.03 (1.29, 3.17) 0.002*
Jaundice
No/cannot remember 2461 (86.1) 91 (77.1) 2552 (85.7) 1.00
Yes 397 (13.9) 27 (22.9) 424 (14.3) 1.84 (1.18, 2.86) 0.007*
Foul-smelling vaginal discharge
No/cannot remember 2272 (79.5) 83 (70.3) 2355 (79.1) 1.00
Yes 586 (20.5) 35 (29.7) 621 (20.9) 1.63 (1.09, 2.45) 0.017*
Gestational age
≥37 weeks 2461 (86.1) 64 (54.2) 2525 (84.8) 1.00
< 37 weeks 397 (13.9) 54 (45.8) 451 (15.2) 5.23 (3.59, 7.63) < 0.001*
CI confidence interval, OR odds ratio
*Includes all live births with survival of more than 7 days
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Discussion
We present data pertaining to 4 years of carefully moni-
toring perinatal mortality and miscarriage from a pri-
marily rural area in south-central Côte d’Ivoire. Our
data stem from an HDSS, which is a well characterised
population-based cohort that is subject to longitudinal
surveillance and thus less prone to underreporting due
to a lack of health system use or incomplete hospital-based
registries. We found lower perinatal mortality and stillbirth
rates compared to previous estimates for whole Côte
d’Ivoire in 2004 and for the urban population of Abidjan
some 20 years ago [30–32]. There are no recent studies on
foetal and early neonatal death rates for Côte d’Ivoire, and
hence, comparison with contemporary national-level data is
not possible [33]. Our estimates of stillbirth rates are in line
with rural settings elsewhere in sub-Saharan Africa that
have been monitored in 2013 [34]. Furthermore, perinatal
mortality, stillbirth, and early neonatal death rates for the
Taabo HDSS are comparable to data obtained from 2002 to
2008 in neighbouring Ghana [35].
We identified a number of risk factors for an un-
favourable foetal or early neonatal outcome, involving
the expectant mothers’ sociodemographic characteristics,
use of preventive measures and health services, and the
experience of pregnancy-related or concomitant health
conditions. Most of these factors are well known to im-
pact negatively on foetal and neonatal health, such as a
preterm birth [5, 36, 37] and a history of earlier miscar-
riage or stillbirth [38–40].
On first sight, the overall rate of pregnant women who
went for antenatal care visits is high (96.3%). However,
our data lack information on the exact number of visits,
the gestation weeks at the time of the health visit, and
the perceived and real quality of care received. A closer
look at our data reveals that only a small proportion of
pregnant women received and benefitted from standard
prevention packages during such visits, such as a rubella
test (4.8%), HIV testing (18.6%), iron/folic acid supple-
mentation (28.0%), and two doses of tetanus vaccination
(44.3%). These observations suggest either a generally
low quality of provided antenatal care or the presence of
stock-outs for material needed for essential interven-
tions. If regular supplies are missing, they are sometimes
still available at higher cost, reducing the number of
women of reproductive age able to receive them. An-
other explanation is related to health seeking behaviour
of the expectant mothers who visited antenatal care only
once and probably at a late stage. Previous research sug-
gests that antenatal care visits and prevention packages
prevent against fatal foetal outcomes [30, 41, 42]. The
low rate of prevention care received urges for a better
coverage in the area and a deeper understanding of
health care service use, since non-beneficiaries of the lat-
ter two measures were at higher risk for a fatal event.
In the Taabo HDSS and other rural areas of Côte
d’Ivoire, infectious diseases are still the dominant cause
of death [21]. Malaria due to Plasmodium falciparum is
highly endemic [43–45] and our results demonstrate
negative consequences on foetal health in mothers suf-
fering from malaria. In Côte d’Ivoire, intermittent pre-
ventive treatment in pregnancy (IPTp) has been adopted
since 2005. However, the effectiveness of protecting the
mothers and unborn child from adverse events from
malaria depend on the rigorous adherence of this policy,
coverage, and the number of antenatal care visits of the
expectant mothers [46, 47]. Furthermore, long-lasting
insecticidal nets (LLINs) are available for malaria pre-
vention. Bacterial infections, such as pneumonia and
sepsis, are key drivers of neonatal death, as previously
reported for the Taabo HDSS [21]. These deaths are pre-
ventable through administration of antibiotics during
perinatal care and through strict observation of hygiene
standards [46, 48]. Furthermore, early recognition and
treatment is a key strategy for survival. Appropriate
screening for urinary tract infections and preeclamp-
sia, which are both known to have detrimental effects
on foetal health [49, 50], is currently not feasible in
the health district of Taabo. Both conditions could,
however, be indirectly assessed as nitrite/leukocyte es-
terase and protein−/albuminuria using urine reagent
strip analysis and, in case of preeclampsia, by specific
Table 4 Significant determinants for fatal foetal outcomes from
multivariable regression analysis (adjusted for age, socioeconomic
status and residency of the mother)
Explanatory variablea aORb 95% CI
Residency (rural) 2.87 1.31, 6.29
Socioeconomic status (poorest) 1.79 1.02, 3.14
Earlier miscarriage/stillbirth 23.19 14.71, 36.55
Delivery (by caesarean section) 13.03 4.24, 40.08
Delivery (instrumental) 5.05 1.50, 16.96
Gestational age (< 37 weeks) 4.45 2.82, 7.01
Delivery cost (chargeable) 0.39 0.25, 0.74
Absence of two doses of tetanus vaccination 2.59 1.56, 4.30
Absence of iron/folic acid supplementation 3.15 1.71, 5.80
Malaria (reported or confirmed) 1.94 1.21, 3.11
Multivariable logistic regression models using the penalized maximum
likelihood estimation (Firth method) [27], to account for rare events, and a
stepwise backward elimination approach were utilised to identify explanatory
variables, which most significantly influence the foetal outcome. Initial models
included (i) sociodemographic (i.e. age, socioeconomic status, and residency of
the mother); (ii) birth circumstances and antenatal care; and (iii) pregnancy-related
morbidity and concomitant health condition variables
Remaining explanatories were included at a significance level of p < 0.2
aReference categories for explanatory variables: socioeconomic status, least
poor; residency, urban; earlier miscarriage, none; delivery, normal; gestational
age, ≥37 weeks; delivery cost, free of charge; two doses of tetanus vaccination,
received; iron/folic acid supplementation, received; malaria (reported or
confirmed), none
bAdjusted odds ratios
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blood pressure measurement to allow for early treat-
ment [49, 51].
Our investigation also revealed a number of
unexpected or contradicting findings that are offered for
discussion. First, caesarean section is a surgical interven-
tion to prevent or mitigate complications during preg-
nancy and childbirth. If applied timely and for
appropriate indications, caesarean section is associated
with lower incidence of stillbirth and early neonatal
death [34, 52]. Among women with a fatal foetal out-
come, 6.8% underwent a caesarean section, compared to
only 1.0% among women with live birth. This finding,
along with an overall low caesarean section rate of 1.2%
(a proportion of 5–15% of births by caesarean section
are considered as an indicator of acceptable EOC
[48, 53]), may indicate that action is taken too late by the
population and health services and reflect lack of access
to, and malfunctioning of, health services. Of note, ac-
cording to our data, more than half of all caesarean sec-
tions were undertaken in village health centres, however
all these facilities do not dispose any operational block
and these cases should thus have been referred to the
Taabo hospital that is better equipped. While this finding
might indicate some reporting mistakes during the ques-
tionnaire interviews about the final place of delivery, we
cannot exclude any unofficially undertaken EOC by local
health staff. A timely detection of malpresentations requir-
ing caesarean section should be offered by midwifes. Con-
ditions like placenta praevia and to a lesser degree foetal
growth restriction as indications for early delivery would
be crucial, but those imply the use of ultrasound [54],
which was not available when our study was conducted.
In contrast to previous studies and international health
efforts to effectively impact on new-born and maternal
health [48, 55], non-facility-based delivery or non-pro-
fessional birth assistance, with exception of no assistance
at all, did not present a significant risk for pregnancy
loss or neonatal death in our study cohort. This is im-
portant in light of half of all deliveries in the observation
period being non-facility-based. This may partly be ex-
plained by more difficult cases rather being handled by
professionals in facilities. However, even if more compli-
cated cases that needed further instrumental interven-
tion were excluded from the analysis, fatality rates for
home deliveries were not significantly increased com-
pared to deliveries taking place in health centres. While
this may be a sign for traditional birth assistants working
well, potentially referring critical cases to health facil-
ities, it may be at the same time an indicator for insuffi-
cient quality of care in health centres. Our findings on
higher numbers of fatal events among non-resident
women using health facilities for delivery might indicate
a selection bias with high-risk pregnancies (including re-
ferrals/transfers) or women with complications tending
to use health facilities as would be desired, but health fa-
cilities unable to provide adequate care either due to late
presentation or a poor level of care available. To pro-
mote facility-based deliveries may thus help to prevent
late detection and arrival in the health centres of women
with delivery complications, which is confirmed by our
results of a lower odds for fatal outcomes in the urban
population, characterised by a higher rate of facility-
based deliveries compared to their rural counterparts
(91.9% vs. 43.6%).
Both, the promotion of facility-based deliveries and
coverage with preventive measures against congenital
malformations and foetal malnutrition supplied during
antenatal visits and against endemic infectious diseases
impacting on maternal and foetal health require a deeper
understanding of local drivers of health care use and
traditional concepts of disease and pregnancy manage-
ment among rural populations [16, 56]. A high risk
among the poorest and rural dwellers may further indicate
inequalities in access to, and use of, ante- and perinatal
health care [57] that needs further scientific inquiry. In
rural and often remote areas, community-based interven-
tion packages, including training of traditional birth at-
tendance, increase of coverage of preventive treatment,
testing and nutritional supplementation as well as aware-
ness campaigns for safe motherhood and neonatal health
have been shown to positively impact on neonatal out-
comes [42]. It is clear that the quality of receiving health
services needs improvement in order to make them at-
tractive, reduce access barriers, and enable them to pro-
vide appropriate, life-saving preventive and curative care.
Although we have tried to include a maximum num-
ber of potential factors influencing birth outcome, cer-
tain conditions known to be negatively related may have
been missed since the current local health care infra-
structure does not allow for its assessment or diagnosis
(e.g. preeclampsia). A number of clinical factors, as
assessed by our questionnaire administered to the ex-
pectant mothers, are based on self-reported symptom-
atology rather than determined through a clinical
examination or a diagnostic device by a professional (e.g.
malaria, jaundice, or urinary tract infection) and may
thus lack accuracy. Likewise the estimation of gestational
age in low-resource settings (including the current
study) is prone to uncertainty since it depends on the
capability of mothers to correctly recall their last men-
strual period. Additionally, other information such as
birth weight are often missing, and hence, estimates of
gestational age are to be interpreted with care. In any
event, mainly qualitatively-assessed clinical factors
should be considered as proxies for the actual infection
status, whereas for the gestational age we would like to
highlight that we only used two categories; namely (i)
pre-term and (ii) term. For relationship analysis, we
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considered the effect from potential misclassification of
births close to this 37-week threshold as negligible for
what was intended to be shown. With regard to the out-
come measures, it is important to highlight that some of
the so-called stillbirths may in fact be misclassified early
neonatal deaths either from non-ability to distinguish
between perinatal asphyxia or driven by cultural prac-
tices and beliefs favouring the interpretation of stillbirth
as often observed in sub-Saharan Africa and thus intro-
ducing a social desirability bias into our analysis [58, 59].
Furthermore some pregnancies that ended in very early
pregnancy loss may have been missed, and hence, the
rate of miscarriage been underreported. Miscarriage is
widely stigmatised, and hence, often remains a hidden
phenomenon [60]. Nonetheless our study benefits from
the use of population-based data that stem from an
HDSS continuously registering vital events of more than
40,000 inhabitants. The monitoring of pregnancies is
characterised by different stages whereas certain aspects
are recorded in regular intervals during the course of
the pregnancy, while others only get assessed once the
outcome of the pregnancy is known. Our main out-
comes such as miscarriage and perinatal mortality are
thus less prone to underreporting compared to studies
relying on hospital-based data repositories [36].
Conclusion
Our data have shown that risk factors for fatal foetal out-
comes in the Taabo HDSS are multifactorial, including the
mother’s socioeconomic status and behaviour vis-à-vis pre-
vention and use of antenatal care. Our results further con-
firmed predisposing conditions in expecting mothers such
as earlier miscarriage or malaria as important factors to be
considered. Hence, there is a pressing need for rigorous
monitoring of high-risk pregnancies and early treatment of
Plasmodium infection. Additionally, at the health system
level, several aspects have been identified to influence birth
outcomes, indicating the need to improve access and qual-
ity of care, especially in terms of early detection of compli-
cated deliveries that could benefit from EOC. The evidence
we provide may indicate how to most effectively tackle ma-
ternal and neonatal health through health system strength-
ening, community intervention packages and awareness
campaigns on already existing services and policies for ex-
pectant mothers in the area. In a next step, however, local
drivers for ante- and perinatal care use, compliance to pre-
ventive measures and community-identified needs for preg-
nant women in the current setting should be assessed, so
that strategies can be tailored to reduce and prevent foetal
and neonatal death.
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